In hepatocellular and prostate cancer, the transcription factors from UPR can bind and activate the promoter of VEGF, which resulting in the proliferation and migration of endothelial cells (Pereira et al., 2014; Ramakrishnan et al., 2014). Here, VEGFA is linked to prostate cancer.